Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Juvenile myasthenia gravis

O C Snead, J W Benton, D Dwyer

    Neurology
    |July 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Titanium alloy response sensitivity to variations in spectral reconstructions of National Ignition Facility xenon line-emission x-ray sources.

    The Review of scientific instruments·2026
    Same author

    Pump with Broadband Probe Experiments for Single-Shot Measurements of Plasma Conditions and Crossed-Beam Energy Transfer.

    Physical review letters·2025
    Same author

    Thermal energy transport in laser-driven high x-ray conversion efficiency metallic silver nanowire foams.

    Physical review. E·2025
    Same author

    Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

    Physical review letters·2024
    Same author

    Soft x-ray power diagnostics for fusion experiments at NIF, Omega, and Z facilities.

    The Review of scientific instruments·2023
    Same author

    Optimized x-ray emission from 10 ns long germanium x-ray sources at the National Ignition Facility.

    The Review of scientific instruments·2022

    Myasthenia gravis in children often begins before age 10, frequently presenting with ocular symptoms. Effective treatment prioritizes medical management over thymectomy, with associated diseases noted in nearly half of cases.

    Area of Science:

    • Pediatric Neurology
    • Autoimmune Disorders
    • Clinical Research

    Background:

    • Myasthenia gravis (MG) is a rare autoimmune disorder affecting neuromuscular junctions.
    • Pediatric MG presents unique diagnostic and management challenges.
    • Understanding disease characteristics in children is crucial for effective care.

    Purpose of the Study:

    • To investigate the clinical presentation, associated conditions, and treatment outcomes in a cohort of pediatric myasthenia gravis patients.
    • To evaluate the efficacy of medical management versus thymectomy in children with MG.
    • To analyze the prevalence and significance of serum IgG antibodies to nicotinic acetylcholine receptors in pediatric MG.

    Main Methods:

    • A longitudinal study of 32 children diagnosed with myasthenia gravis over 12 years.

    Related Experiment Videos

  • Data collection included age at onset, clinical presentation, co-existing medical conditions, antibody titers, and treatment responses.
  • Comparison of treatment effectiveness between medical interventions and thymectomy.

    • Main Results:

    • The mean age of onset was 7.7 years, with 63% presenting with ocular symptoms.
    • Comorbidities were present in 44% of patients, most commonly seizure disorders.
    • Serum IgG nicotinic acetylcholine receptor antibodies were found in 53% of patients, with no correlation to disease severity or treatment response.
    • Medical management was effective in 63% of cases, while thymectomy was effective in only 28%.

    Conclusions:

    • Pediatric myasthenia gravis commonly manifests before age 10 and is frequently associated with other medical conditions.
    • Serum IgG nicotinic acetylcholine receptor antibody prevalence in children with MG is lower than in adults.
    • Aggressive medical management should be the primary treatment approach before considering thymectomy in pediatric MG patients.